Fundraising FoxDOSE Therapeutics
Dallas, US · Founded 2021 · Delaware corporation
Find your way into DOSE Therapeutics
Sign up to see every warm intro you have to DOSE Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DOSE Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MT
McHenry T. TichenorNamed on SEC filing
SL
Steven L. McknightNamed on SEC filing
MB
Michael BakesNamed on SEC filing
BL
Blair LapointeNamed on SEC filing
JF
John Fulton MurrayNamed on SEC filing
DN
Deepak NijhawanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2022
▶$10MraisedMay 2022 · 20 investors · BiotechnologyRule 506(b)
▶$10MraisedMay 2022 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- McHenry T. TichenorDirector
- Steven L. McknightDirector
- Michael BakesExecutive Officer
- Blair LapointeDirector
- John Fulton MurrayExecutive Officer, Director
- Deepak NijhawanDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Proceeds to insiders
- $380K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has DOSE Therapeutics raised?
- DOSE Therapeutics has disclosed $10M raised across 1 round.
- Where is DOSE Therapeutics headquartered?
- DOSE Therapeutics is headquartered in Dallas, US.